Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002008499-26-000002
Filing Date
2026-01-06
Accepted
2026-01-06 16:47:47
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1767736064.html 4  
1 FORM 4 wk-form4_1767736064.xml 4 4366
  Complete submission text file 0002008499-26-000002.txt   5823
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Issuer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALTO NEUROSCIENCE, INC. 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address
York Gwill (Reporting) CIK: 0002008499 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41944 | Film No.: 26512422